IDEXX LABORATORIES INC (IDXX) Fundamental Analysis & Valuation
NASDAQ:IDXX • US45168D1046
Current stock price
591.485 USD
+5.12 (+0.87%)
Last:
This IDXX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. IDXX Profitability Analysis
1.1 Basic Checks
- IDXX had positive earnings in the past year.
- IDXX had a positive operating cash flow in the past year.
- Each year in the past 5 years IDXX has been profitable.
- Each year in the past 5 years IDXX had a positive operating cash flow.
1.2 Ratios
- With an excellent Return On Assets value of 31.62%, IDXX belongs to the best of the industry, outperforming 99.46% of the companies in the same industry.
- With an excellent Return On Equity value of 65.99%, IDXX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
- The Return On Invested Capital of IDXX (41.85%) is better than 100.00% of its industry peers.
- IDXX had an Average Return On Invested Capital over the past 3 years of 37.64%. This is significantly above the industry average of 9.18%.
- The last Return On Invested Capital (41.85%) for IDXX is above the 3 year average (37.64%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 31.62% | ||
| ROE | 65.99% | ||
| ROIC | 41.85% |
ROA(3y)28.17%
ROA(5y)27.96%
ROE(3y)59.52%
ROE(5y)79.62%
ROIC(3y)37.64%
ROIC(5y)38.05%
1.3 Margins
- IDXX has a Profit Margin of 24.62%. This is amongst the best in the industry. IDXX outperforms 95.65% of its industry peers.
- IDXX's Profit Margin has improved in the last couple of years.
- Looking at the Operating Margin, with a value of 31.60%, IDXX belongs to the top of the industry, outperforming 98.91% of the companies in the same industry.
- IDXX's Operating Margin has improved in the last couple of years.
- IDXX's Gross Margin of 61.80% is fine compared to the rest of the industry. IDXX outperforms 64.13% of its industry peers.
- In the last couple of years the Gross Margin of IDXX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 31.6% | ||
| PM (TTM) | 24.62% | ||
| GM | 61.8% |
OM growth 3Y5.77%
OM growth 5Y4.3%
PM growth 3Y6.87%
PM growth 5Y2.75%
GM growth 3Y1.26%
GM growth 5Y1.26%
2. IDXX Health Analysis
2.1 Basic Checks
- IDXX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- The number of shares outstanding for IDXX has been reduced compared to 1 year ago.
- The number of shares outstanding for IDXX has been reduced compared to 5 years ago.
- The debt/assets ratio for IDXX has been reduced compared to a year ago.
2.2 Solvency
- IDXX has an Altman-Z score of 21.44. This indicates that IDXX is financially healthy and has little risk of bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 21.44, IDXX belongs to the top of the industry, outperforming 96.20% of the companies in the same industry.
- IDXX has a debt to FCF ratio of 0.81. This is a very positive value and a sign of high solvency as it would only need 0.81 years to pay back of all of its debts.
- The Debt to FCF ratio of IDXX (0.81) is better than 90.22% of its industry peers.
- IDXX has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
- IDXX has a Debt to Equity ratio (0.48) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | 0.81 | ||
| Altman-Z | 21.44 |
ROIC/WACC4.18
WACC10.01%
2.3 Liquidity
- A Current Ratio of 1.23 indicates that IDXX should not have too much problems paying its short term obligations.
- IDXX has a Current ratio of 1.23. This is amonst the worse of the industry: IDXX underperforms 82.61% of its industry peers.
- A Quick Ratio of 0.90 indicates that IDXX may have some problems paying its short term obligations.
- With a Quick ratio value of 0.90, IDXX is not doing good in the industry: 80.43% of the companies in the same industry are doing better.
- IDXX does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.23 | ||
| Quick Ratio | 0.9 |
3. IDXX Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an nice 16.18% over the past year.
- IDXX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.26% yearly.
- IDXX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.42%.
- Measured over the past years, IDXX shows a quite strong growth in Revenue. The Revenue has been growing by 9.72% on average per year.
EPS 1Y (TTM)16.18%
EPS 3Y17.63%
EPS 5Y14.26%
EPS Q2Q%17.56%
Revenue 1Y (TTM)10.42%
Revenue growth 3Y8.52%
Revenue growth 5Y9.72%
Sales Q2Q%14.28%
3.2 Future
- Based on estimates for the next years, IDXX will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.75% on average per year.
- The Revenue is expected to grow by 9.46% on average over the next years. This is quite good.
EPS Next Y13.42%
EPS Next 2Y13.06%
EPS Next 3Y13.18%
EPS Next 5Y13.75%
Revenue Next Year9.13%
Revenue Next 2Y8.86%
Revenue Next 3Y8.98%
Revenue Next 5Y9.46%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. IDXX Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 45.26, IDXX can be considered very expensive at the moment.
- IDXX's Price/Earnings ratio is a bit cheaper when compared to the industry. IDXX is cheaper than 69.02% of the companies in the same industry.
- IDXX is valuated expensively when we compare the Price/Earnings ratio to 25.96, which is the current average of the S&P500 Index.
- The Price/Forward Earnings ratio is 39.90, which means the current valuation is very expensive for IDXX.
- Based on the Price/Forward Earnings ratio, IDXX is valued a bit cheaper than 68.48% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 24.04. IDXX is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 45.26 | ||
| Fwd PE | 39.9 |
4.2 Price Multiples
- 69.02% of the companies in the same industry are more expensive than IDXX, based on the Enterprise Value to EBITDA ratio.
- IDXX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. IDXX is cheaper than 73.91% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 45.13 | ||
| EV/EBITDA | 31.2 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IDXX does not grow enough to justify the current Price/Earnings ratio.
- IDXX has an outstanding profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as IDXX's earnings are expected to grow with 13.18% in the coming years.
PEG (NY)3.37
PEG (5Y)3.17
EPS Next 2Y13.06%
EPS Next 3Y13.18%
5. IDXX Dividend Analysis
5.1 Amount
- No dividends for IDXX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
IDXX Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:IDXX (3/17/2026, 2:19:23 PM)
591.485
+5.12 (+0.87%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-02 2026-02-02/bmo
Earnings (Next)04-29 2026-04-29/bmo
Inst Owners95.39%
Inst Owner Change11.38%
Ins Owners0.21%
Ins Owner Change1.92%
Market Cap47.09B
Revenue(TTM)4.30B
Net Income(TTM)1.06B
Analysts80.91
Price Target768.59 (29.94%)
Short Float %2.22%
Short Ratio3.4
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.79%
Min EPS beat(2)3.12%
Max EPS beat(2)6.47%
EPS beat(4)4
Avg EPS beat(4)4.78%
Min EPS beat(4)1.72%
Max EPS beat(4)7.81%
EPS beat(8)8
Avg EPS beat(8)4.3%
EPS beat(12)12
Avg EPS beat(12)4.65%
EPS beat(16)14
Avg EPS beat(16)3.71%
Revenue beat(2)1
Avg Revenue beat(2)0.36%
Min Revenue beat(2)-0.31%
Max Revenue beat(2)1.03%
Revenue beat(4)2
Avg Revenue beat(4)0.17%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)1.88%
Revenue beat(8)3
Avg Revenue beat(8)-0.74%
Revenue beat(12)3
Avg Revenue beat(12)-1%
Revenue beat(16)3
Avg Revenue beat(16)-1.15%
PT rev (1m)-1.63%
PT rev (3m)-0.59%
EPS NQ rev (1m)-0.44%
EPS NQ rev (3m)0.55%
EPS NY rev (1m)0.05%
EPS NY rev (3m)0.63%
Revenue NQ rev (1m)0.44%
Revenue NQ rev (3m)1.42%
Revenue NY rev (1m)0.19%
Revenue NY rev (3m)0.32%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 45.26 | ||
| Fwd PE | 39.9 | ||
| P/S | 10.94 | ||
| P/FCF | 45.13 | ||
| P/OCF | 39.85 | ||
| P/B | 29.34 | ||
| P/tB | 43.54 | ||
| EV/EBITDA | 31.2 |
EPS(TTM)13.07
EY2.21%
EPS(NY)14.82
Fwd EY2.51%
FCF(TTM)13.11
FCFY2.22%
OCF(TTM)14.84
OCFY2.51%
SpS54.05
BVpS20.16
TBVpS13.58
PEG (NY)3.37
PEG (5Y)3.17
Graham Number77
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 31.62% | ||
| ROE | 65.99% | ||
| ROCE | 61.77% | ||
| ROIC | 41.85% | ||
| ROICexc | 44.96% | ||
| ROICexgc | 57.39% | ||
| OM | 31.6% | ||
| PM (TTM) | 24.62% | ||
| GM | 61.8% | ||
| FCFM | 24.25% |
ROA(3y)28.17%
ROA(5y)27.96%
ROE(3y)59.52%
ROE(5y)79.62%
ROIC(3y)37.64%
ROIC(5y)38.05%
ROICexc(3y)42.76%
ROICexc(5y)42.28%
ROICexgc(3y)54.98%
ROICexgc(5y)55.56%
ROCE(3y)53.48%
ROCE(5y)55.19%
ROICexgc growth 3Y6.58%
ROICexgc growth 5Y1.33%
ROICexc growth 3Y7.31%
ROICexc growth 5Y1.49%
OM growth 3Y5.77%
OM growth 5Y4.3%
PM growth 3Y6.87%
PM growth 5Y2.75%
GM growth 3Y1.26%
GM growth 5Y1.26%
F-Score8
Asset Turnover1.28
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | 0.81 | ||
| Debt/EBITDA | 0.51 | ||
| Cap/Depr | 95.21% | ||
| Cap/Sales | 3.21% | ||
| Interest Coverage | 36.08 | ||
| Cash Conversion | 78.51% | ||
| Profit Quality | 98.5% | ||
| Current Ratio | 1.23 | ||
| Quick Ratio | 0.9 | ||
| Altman-Z | 21.44 |
F-Score8
WACC10.01%
ROIC/WACC4.18
Cap/Depr(3y)104.09%
Cap/Depr(5y)113.7%
Cap/Sales(3y)3.41%
Cap/Sales(5y)3.73%
Profit Quality(3y)93.28%
Profit Quality(5y)84.36%
High Growth Momentum
Growth
EPS 1Y (TTM)16.18%
EPS 3Y17.63%
EPS 5Y14.26%
EPS Q2Q%17.56%
EPS Next Y13.42%
EPS Next 2Y13.06%
EPS Next 3Y13.18%
EPS Next 5Y13.75%
Revenue 1Y (TTM)10.42%
Revenue growth 3Y8.52%
Revenue growth 5Y9.72%
Sales Q2Q%14.28%
Revenue Next Year9.13%
Revenue Next 2Y8.86%
Revenue Next 3Y8.98%
Revenue Next 5Y9.46%
EBIT growth 1Y20.53%
EBIT growth 3Y14.78%
EBIT growth 5Y14.44%
EBIT Next Year22.71%
EBIT Next 3Y14.82%
EBIT Next 5Y15.18%
FCF growth 1Y30.76%
FCF growth 3Y39.53%
FCF growth 5Y14.08%
OCF growth 1Y27.21%
OCF growth 3Y29.59%
OCF growth 5Y12.77%
IDEXX LABORATORIES INC / IDXX Fundamental Analysis FAQ
What is the ChartMill fundamental rating of IDEXX LABORATORIES INC (IDXX) stock?
ChartMill assigns a fundamental rating of 7 / 10 to IDXX.
What is the valuation status of IDEXX LABORATORIES INC (IDXX) stock?
ChartMill assigns a valuation rating of 4 / 10 to IDEXX LABORATORIES INC (IDXX). This can be considered as Fairly Valued.
Can you provide the profitability details for IDEXX LABORATORIES INC?
IDEXX LABORATORIES INC (IDXX) has a profitability rating of 9 / 10.
What are the PE and PB ratios of IDEXX LABORATORIES INC (IDXX) stock?
The Price/Earnings (PE) ratio for IDEXX LABORATORIES INC (IDXX) is 45.26 and the Price/Book (PB) ratio is 29.34.
What is the expected EPS growth for IDEXX LABORATORIES INC (IDXX) stock?
The Earnings per Share (EPS) of IDEXX LABORATORIES INC (IDXX) is expected to grow by 13.42% in the next year.